BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Gotham Therapeutics

Gotham Therapeutics logo

Founded
2017
Geography
United States of America based
Funding
$54 M

Gotham Therapeutics has assembled an exceptional team and network to establish a novel drug class targeting RNA-modifying proteins. By changing the activity of proteins that modify messenger RNA, we aim to develop new treatment options for patients suffering from cancers, auto-immune and neurodegenerative diseases. We are applying a 360-degree approach to small molecule drug design to build a pipeline based on the promise of this rapidly emerging biopharmaceutical field.

Technologies

Pharmaceutical and Drug Discovery   RNA-focused Startups  

R&D Platform


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet